For simple transfers that do not involve intellectual property, the NIH recommends a simple letter agreement. For materials that can be patented or for which more protection is desired, the Uniform Biological Material Transfer Agreement (UBMTA) can be used. Many U.S. educational institutions have signed the UBMTA Framework Agreement.  AUTM (formerly Association of University Technology Managers) serves as a reference for the original UBMTA master agreements and maintains the list of signatories.  UBMTA signatories only need to sign an implementation letter containing the details of each transfer, as they have already accepted all the terms of the framework agreement. Otherwise, companies can add all the conditions they want to share their materials and, sometimes, these provisions, expressed in terms of contractual conditions, are incompatible with academic guidelines and values. If it is not negotiable, the conditions may prevent the material from being obtained. Nevertheless, in these situations, the PMI does everything in its power to find common ground with the companies` suppliers and reach agreements. If the signature of a master controller is required for the material transfer agreement, send two hard copies of the MTA each with an original signature to Andy Chen in the Office of Industry Engagement. It is important to recognize that materials purchased from industry under material transfer agreements are not free of charge. In addition to the costs incurred by the university due to the administrative burden of negotiating EPAs and the time lost during negotiations, the rights that companies wait for to obtain discoveries made with the material can be worth hundreds of thousands of dollars.
The Principal Investigator and/or staff supplement, if necessary, the WISPER data set with the help of the department administration. Questions relating to this procedure should first be addressed to division administrators trained to conclude agreements at WISPER. Note in particular the following points in the WISPER that must be fulfilled for material transfer agreements: the University of Wisconsin-Madison directive does not require the existence of material transfer agreements prior to the sending of materials by the university, unless they are human tissues or samples resulting from research carried out under a protocol approved by the Institutional Review Board (IRB). In this case, the IRB authorization must be in place. Based on the knowledge gained, AUTM has developed a toolkit to promote the use of standard agreements. It contains a decision tree that helps technology transfer professionals choose an appropriate agreement for the transfer, contains easy-to-use forms for existing NIH models, and a new set of model agreements that modify the UBMTA to make them more adaptable to a wider variety of situations: these ATMs can take weeks or months and require the investment of thousands of dollars in administrative burdens. . . .